Patents by Inventor Bhavin Y. Gajera

Bhavin Y. Gajera has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RESPIRATORY TRACT DELIVERY OF LEVODOPA AND DOPA DECARBOXYLASE INHIBITOR FOR TREATMENT OF PARKINSON'S DISEASE
    Publication number: 20230301955
    Abstract: A dry pharmaceutical composition is provided that is suitable for respiratory tract delivery of levodopa and DDI for treatment of Parkinson's disease or Parkinson syndrome. The dry pharmaceutical composition comprises levodopa, a dopa decarboxylase inhibitor (DDI) and at least one excipient. A unit dosage form of the dry pharmaceutical composition and a method of treating a patient with Parkinson's disease or Parkinson syndrome by administering the dry pharmaceutical composition are also provided.
    Type: Application
    Filed: May 6, 2023
    Publication date: September 28, 2023
    Inventors: John D. Hoekman, Kelsey H. Satterly, Inna Dashevsky, Aditya R. Das, Stephen B. Shrewsbury, Gregory J. Davies, Bhavin Y. Gajera
  • Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's disease
    Patent number: 11690819
    Abstract: A dry pharmaceutical composition is provided that is suitable for respiratory tract delivery of levodopa and DDI for treatment of Parkinson's disease or Parkinson syndrome. The dry pharmaceutical composition comprises levodopa, a dopa decarboxylase inhibitor (DDI) and at least one excipient. A unit dosage form of the dry pharmaceutical composition and a method of treating a patient with Parkinson's disease or Parkinson syndrome by administering the dry pharmaceutical composition are also provided.
    Type: Grant
    Filed: February 28, 2022
    Date of Patent: July 4, 2023
    Assignee: Impel Pharmaceuticals Inc.
    Inventors: John D. Hoekman, Kelsey H. Satterly, Inna Dashevsky, Aditya R. Das, Stephen B. Shrewsbury, Gregory J. Davies, Bhavin Y. Gajera
  • Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's Disease
    Patent number: 11517548
    Abstract: A dry pharmaceutical composition is provided that is suitable for respiratory tract delivery of levodopa and DDI for treatment of Parkinson's disease or Parkinson syndrome. The dry pharmaceutical composition comprises levodopa, a dopa decarboxylase inhibitor (DDI) and at least one excipient. A unit dosage form of the dry pharmaceutical composition and a method of treating a patient with Parkinson's disease or Parkinson syndrome by administering the dry pharmaceutical composition are also provided.
    Type: Grant
    Filed: July 19, 2019
    Date of Patent: December 6, 2022
    Assignee: Impel Pharmaceuticals Inc.
    Inventors: John D. Hoekman, Kelsey H. Satterly, Inna Dashevsky, Aditya R. Das, Stephen B. Shrewsbury, Gregory J. Davies, Bhavin Y. Gajera
  • RESPIRATORY TRACT DELIVERY OF LEVODOPA AND DOPA DECARBOXYLASE INHIBITOR FOR TREATMENT OF PARKINSON'S DISEASE
    Publication number: 20220233486
    Abstract: A dry pharmaceutical composition is provided that is suitable for respiratory tract delivery of levodopa and DDI for treatment of Parkinson's disease or Parkinson syndrome. The dry pharmaceutical composition comprises levodopa, a dopa decarboxylase inhibitor (DDI) and at least one excipient. A unit dosage form of the dry pharmaceutical composition and a method of treating a patient with Parkinson's disease or Parkinson syndrome by administering the dry pharmaceutical composition are also provided.
    Type: Application
    Filed: February 28, 2022
    Publication date: July 28, 2022
    Inventors: John D. Hoekman, Kelsey H. Satterly, Inna Dashevsky, Aditya R. Das, Stephen B. Shrewsbury, Gregory J. Davies, Bhavin Y. Gajera
  • RESPIRATORY TRACT DELIVERY OF LEVODOPA AND DOPA DECARBOXYLASE INHIBITOR FOR TREATMENT OF PARKINSON'S DISEASE
    Publication number: 20200046667
    Abstract: A dry pharmaceutical composition is provided that is suitable for respiratory tract delivery of levodopa and DDI for treatment of Parkinson's disease or Parkinson syndrome. The dry pharmaceutical composition comprises levodopa, a dopa decarboxylase inhibitor (DDI) and at least one excipient. A unit dosage form of the dry pharmaceutical composition and a method of treating a patient with Parkinson's disease or Parkinson syndrome by administering the dry pharmaceutical composition are also provided.
    Type: Application
    Filed: July 19, 2019
    Publication date: February 13, 2020
    Inventors: John D. Hoekman, Kelsey H. Satterly, Inna Dashevsky, Aditya R. Das, Stephen B. Shrewsbury, Gregory J. Davies, Bhavin Y. Gajera